Senators Just Unveiled a Sweeping New Opioid Bill

Membership Ticker

Support Mother Jones with a year-end donation

Here are the facts: 1) We urgently need to raise $350,000 in online donations this month; 2) Readers told us fundraising is annoying; 3) Both journalism and US democracy are in trouble. So, to make this as un-annoying as possible, we’re hoping less is more right now—and we focus on three simple questions: Why us, why now, and why does your support for our journalism matter? We need a lot of help this month and can’t afford to come up short again. Please make a year-end gift if you can right now.

We need to raise $350,000 in online donations this month to keep Mother Jones charging hard. But readers told us fundraising is annoying, and we don’t want to add to the overwhelming noise. So we’re hoping less is more right now, and that we can “Let the Facts Speak for Themselves” in making the case for the year-end gifts we need. Please help if you can right now.

Charles Wollertz/iStock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

On Tuesday, a bipartisan group of eight senators unveiled a bill that would limit initial painkiller prescriptions to three days and authorize $1 billion for addiction treatment and prevention. If passed, the CARA 2.0 Act, a follow-up to 2016’s Comprehensive Addiction and Recovery Act, will be the most significant legislation addressing the opioid epidemic since President Donald Trump took office.

Here are some more details on what the bill would do:

Limit initial prescriptions for opioids to three days (with the exception of cancer or end-of-life care), which aligns with the prescribing guidelines published by the Centers for Disease Control and Prevention in 2016
Eliminate barriers to prescribing buprenorphine, a gold-standard addiction medication, by making permanent a temporary provision allowing nurse practitioners and physician assistants to prescribe the medication. The bill would also allow states to waive the current cap on the number of buprenorphine patients per physician.
Require physicians to use prescription drug monitoring programs to see if a patient is already being prescribed opioids from a different provider
Require the federal government to come up with national standards for addiction recovery housing
Increase civil penalties for opioid manufacturers that don’t report suspicious orders of opioids
Authorize $1 billion to expand access to medication-assisted treatment, equip first responders with the overdose reversal drug naloxone, and provide recovery services to pregnant and postpartum women, veterans, and other vulnerable populations

All told, the legislation lines up with the recommendations put forth by both Trump’s opioid commission last year and and the surgeon general’s addiction report under President Barack Obama in 2016. CARA 2.0’s sponsors, evenly split between Democrats and Republicans, included Sens. Maria Cantwell (D-Wash.), Shelley Moore Capito (R-W.V.), Bill Cassidy (R-La.), Maggie Hassan (D-N.H.)Amy Klobuchar (D-Minn.), Rob Portman (R-Ohio),Dan Sullivan (R-Ark.), and Sheldon Whitehouse (D-R.I.).

The bill is part of an ongoing effort in both chambers to quickly identify how best to use the additional $6 billion that the two-year budget, passed by Congress last month, allocated to address the epidemic. (Many say $6 billion isn’t nearly enough to combat a crisis of such historic proportions—for reference, a White House report pegged the cost of the epidemic in 2015 at $504 billion.)

Meanwhile, the White House is holding an opioid summit on Thursday, where Trump advisor Kellyanne Conway, who is spearheading the White House’s response to the epidemic, is expected to speak.